MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$1,081,500K
Net Income
-$107,100K
Net Profit Margin
-9.90%
EPS
-$0.4
Unit: Thousand (K) dollars
Revenue Breakdown
Toric And Multifocal
Sphere Other
Office And Surgical
Fertility
Revenue Breakdown
US
Europe
Rest Of World Excluding United S...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-04-30
2026-01-31
2025-10-31
2025-07-31
Net sales
1,081,500
1,024,100
1,065,100
1,060,300
Cost of sales
346,100
328,900
414,300
368,300
Gross profit
735,400
695,200
650,800
692,000
Selling, general and administrative expense
676,200
390,200
419,200
421,700
Research and development expense
42,500
44,300
41,400
44,600
Amortization of intangibles
47,700
47,900
49,800
50,000
Operating income (loss)
-31,000
212,800
140,400
175,700
Interest expense
20,900
22,400
24,400
25,400
Other (income) expense, net
3,500
1,800
800
1,600
Income (loss) before income taxes
-48,400
192,200
116,800
151,900
Provision for income taxes (note 5)
29,500
61,400
32,200
53,600
Net income (loss)
-77,900
130,800
84,600
98,300
Cash flow hedges
400
-4,000
-
3,900
Foreign currency translation adjustment
-29,600
76,500
-
-3,700
Comprehensive income (loss)
-107,100
203,300
-
98,500
Basic EPS
-0.4
0.67
0.278
0.49
Diluted EPS
-0.4
0.66
0.278
0.49
Basic Average Shares
195,000,000
195,800,000
197,500,000
199,300,000
Diluted Average Shares
195,000,000
196,700,000
198,100,000
200,000,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Comprehensive income (loss)
-$107,100K
(-157.64%↓ Y/Y)
Cash flow hedges
$400K
(102.04%↑ Y/Y)
Toric And Multifocal
$364,900K
(11.11%↑ Y/Y)
Sphere Other
$358,600K
(5.10%↑ Y/Y)
Office And Surgical
$214,200K
(4.08%↑ Y/Y)
Fertility
$143,800K
(13.32%↑ Y/Y)
Net income (loss)
-$77,900K
(-188.83%↓ Y/Y)
Foreign currency
translation adjustment
-$29,600K
(-125.15%↓ Y/Y)
Coopervision Segment
$723,500K
(8.05%↑ Y/Y)
Coopersurgical Segment
$358,000K
(7.60%↑ Y/Y)
Income (loss) before
income taxes
-$48,400K
(-133.49%↓ Y/Y)
Provision for income taxes
(note 5)
$29,500K
(-48.06%↓ Y/Y)
Other (income)
expense, net
$3,500K
(121.74%↑ Y/Y)
Net sales
$1,081,500K
(7.90%↑ Y/Y)
Operating income (loss)
-$31,000K
(-116.77%↓ Y/Y)
Interest expense
$20,900K
(-13.64%↓ Y/Y)
Gross profit
$735,400K
(8.29%↑ Y/Y)
Cost of sales
$346,100K
(7.09%↑ Y/Y)
Selling, general and
administrative expense
$676,200K
(69.47%↑ Y/Y)
Amortization of intangibles
$47,700K
(-4.22%↓ Y/Y)
Research and development
expense
$42,500K
(-6.59%↓ Y/Y)
Buy us a coffee
COOPER COMPANIES, INC. (COO)
COOPER COMPANIES, INC. (COO)